TIAA CREF Investment Management’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-131,881
| Closed | -$2.34M | – | 3049 |
|
|
2018
Q3 | $2.34M | Sell |
131,881
-10,718
| -8% | -$190K | ﹤0.01% | 2047 |
|
|
2018
Q2 | $1.97M | Buy |
+142,599
| New | +$1.97M | ﹤0.01% | 2183 |
|
|
2017
Q2 | – | Sell |
-133,055
| Closed | -$342K | – | 3219 |
|
|
2017
Q1 | $342K | Sell |
133,055
-4,503
| -3% | -$11.6K | ﹤0.01% | 2900 |
|
|
2016
Q4 | $351K | Sell |
137,558
-3,010
| -2% | -$7.68K | ﹤0.01% | 2940 |
|
|
2016
Q3 | $434 | Hold |
140,568
| – | – | ﹤0.01% | 2909 |
|
|
2016
Q2 | $451K | Buy |
140,568
+3,507
| +3% | +$11.3K | ﹤0.01% | 2903 |
|
|
2016
Q1 | $425K | Hold |
137,061
| – | – | ﹤0.01% | 2832 |
|
|
2015
Q4 | $550K | Sell |
137,061
-46,753
| -25% | -$188K | ﹤0.01% | 2861 |
|
|
2015
Q3 | $842K | Buy |
183,814
+27,541
| +18% | +$126K | ﹤0.01% | 2667 |
|
|
2015
Q2 | $811K | Buy |
156,273
+15,412
| +11% | +$80K | ﹤0.01% | 2798 |
|
|
2015
Q1 | $882K | Buy |
140,861
+6,863
| +5% | +$43K | ﹤0.01% | 2683 |
|
|
2014
Q4 | $843K | Sell |
133,998
-14,002
| -9% | -$88.1K | ﹤0.01% | 2749 |
|
|
2014
Q3 | $900K | Buy |
148,000
+125
| +0.1% | +$760 | ﹤0.01% | 2694 |
|
|
2014
Q2 | $974K | Buy |
147,875
+30,472
| +26% | +$201K | ﹤0.01% | 2737 |
|
|
2014
Q1 | $2.8M | Sell |
117,403
-4,558
| -4% | -$109K | ﹤0.01% | 2029 |
|
|
2013
Q4 | $1.3M | Sell |
121,961
-52,297
| -30% | -$559K | ﹤0.01% | 2509 |
|
|
2013
Q3 | $2.32M | Sell |
174,258
-14,938
| -8% | -$199K | ﹤0.01% | 2110 |
|
|
2013
Q2 | $2.48M | Buy |
+189,196
| New | +$2.48M | ﹤0.01% | 2027 |
|